Viral Sequencing to Investigate Sources of SARS-CoV-2 Infection in US Healthcare Personnel.
SARS-CoV-2
healthcare personnel
infection control
precision epidemiology
viral sequencing
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
15 09 2021
15 09 2021
Historique:
received:
15
02
2021
pubmed:
16
4
2021
medline:
24
9
2021
entrez:
15
4
2021
Statut:
ppublish
Résumé
Healthcare personnel (HCP) are at increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We posit that current infection control guidelines generally protect HCP from SARS-CoV-2 infection in a healthcare setting. In this retrospective case series, we used viral genomics to investigate the likely source of SARS-CoV-2 infection in HCP at a major academic medical institution in the Upper Midwest of the United States between 25 March and 27 December 2020. We obtained limited epidemiological data through informal interviews and review of the electronic health record and combined this information with healthcare-associated viral sequences and viral sequences collected in the broader community to infer the most likely source of infection in HCP. We investigated SARS-CoV-2 infection clusters involving 95 HCP and 137 possible patient contact sequences. The majority of HCP infections could not be linked to a patient or coworker (55 of 95 [57.9%]) and were genetically similar to viruses circulating concurrently in the community. We found that 10.5% of HCP infections (10 of 95) could be traced to a coworker. Strikingly, only 4.2% (4 of 95) could be traced to a patient source. Infections among HCP add further strain to the healthcare system and put patients, HCP, and communities at risk. We found no evidence for healthcare-associated transmission in the majority of HCP infections evaluated. Although we cannot rule out the possibility of cryptic healthcare-associated transmission, it appears that HCP most commonly become infected with SARS-CoV-2 via community exposure. This emphasizes the ongoing importance of mask wearing, physical distancing, robust testing programs, and rapid distribution of vaccines.
Sections du résumé
BACKGROUND
Healthcare personnel (HCP) are at increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We posit that current infection control guidelines generally protect HCP from SARS-CoV-2 infection in a healthcare setting.
METHODS
In this retrospective case series, we used viral genomics to investigate the likely source of SARS-CoV-2 infection in HCP at a major academic medical institution in the Upper Midwest of the United States between 25 March and 27 December 2020. We obtained limited epidemiological data through informal interviews and review of the electronic health record and combined this information with healthcare-associated viral sequences and viral sequences collected in the broader community to infer the most likely source of infection in HCP.
RESULTS
We investigated SARS-CoV-2 infection clusters involving 95 HCP and 137 possible patient contact sequences. The majority of HCP infections could not be linked to a patient or coworker (55 of 95 [57.9%]) and were genetically similar to viruses circulating concurrently in the community. We found that 10.5% of HCP infections (10 of 95) could be traced to a coworker. Strikingly, only 4.2% (4 of 95) could be traced to a patient source.
CONCLUSIONS
Infections among HCP add further strain to the healthcare system and put patients, HCP, and communities at risk. We found no evidence for healthcare-associated transmission in the majority of HCP infections evaluated. Although we cannot rule out the possibility of cryptic healthcare-associated transmission, it appears that HCP most commonly become infected with SARS-CoV-2 via community exposure. This emphasizes the ongoing importance of mask wearing, physical distancing, robust testing programs, and rapid distribution of vaccines.
Identifiants
pubmed: 33857303
pii: 6226897
doi: 10.1093/cid/ciab281
pmc: PMC8083259
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1329-e1336Subventions
Organisme : NIAID NIH HHS
ID : DP2 AI144244
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008692
Pays : United States
Organisme : NLM NIH HHS
ID : T15 LM007359
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : 1DP2AI144244-01
Organisme : NIAID NIH HHS
ID : F30 AI145182
Pays : United States
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Références
J Infect Dis. 2018 Sep 22;218(9):1485-1489
pubmed: 29873767
Trends Ecol Evol. 2015 Jun;30(6):306-13
pubmed: 25887947
Emerg Infect Dis. 2020 Oct;26(10):2489-2491
pubmed: 32758345
Nat Protoc. 2017 Jun;12(6):1261-1276
pubmed: 28538739
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Lancet Infect Dis. 2020 Nov;20(11):1263-1271
pubmed: 32679081
JAMA Netw Open. 2020 May 1;3(5):e209687
pubmed: 32437571
JAMA Netw Open. 2021 Mar 1;4(3):e211283
pubmed: 33688967
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
Nat Commun. 2020 Nov 3;11(1):5558
pubmed: 33144575
Clin Epidemiol Glob Health. 2021 Jan-Mar;9:157-161
pubmed: 32869006
Am J Infect Control. 2017 Feb 1;45(2):170-179
pubmed: 28159067
J Biotechnol. 2017 Feb 10;243:16-24
pubmed: 28042011
J Infect Dis. 2018 Sep 8;218(8):1261-1271
pubmed: 29917114
J Clin Microbiol. 2016 Dec 28;55(1):177-182
pubmed: 27795347
Int J Soc Psychiatry. 2021 Feb;67(1):84-89
pubmed: 32635786
Lancet Infect Dis. 2020 Nov;20(11):1273-1280
pubmed: 32622380
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Nat Med. 2019 Feb;25(2):206-211
pubmed: 30728537
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Ann Intern Med. 2020 Jul 21;173(2):120-136
pubmed: 32369541
Infect Control Hosp Epidemiol. 2021 Feb;42(2):229-232
pubmed: 33040753